FEMALE SEXUAL DYSFUNCTION-DRUG THERAPY. Dr. Renee Horowitz M.D FACOG Woman s Urology Center Beaumont Hospital
|
|
- Shannon Campbell
- 6 years ago
- Views:
Transcription
1 FEMALE SEXUAL DYSFUNCTION-DRUG THERAPY Dr. Renee Horowitz M.D FACOG Woman s Urology Center Beaumont Hospital
2 CONFLICT OF INTEREST SPEAKER: AMAG PHARMACEUTICALS LUMENIS
3 DEFINITIONS DSM-IV VS DSM-V DSM IV SEPARATED HSDD AND AROUSAL DISORDERS DSM-V COMBINED THEM INTO FEMALE SEXUAL INTEREST AND AROUSAL DISORDER (FSIAD) ISSWSH AND THE INTERNATIONAL CONSULTATION OF SEXUAL MEDICINE COMMITTEE ON DEFINITIONS CONSENSUS IMPORTANT TO CHARACTERIZE THE ASSESSMENT OF EACH DISORDER WHILE UNDERSTANDING THERE IS OVERLAP TREATMENT IS BASED ON THE PRIMARY DISORDER IDENTIFIED BY WOMEN
4 ISSWSH DEFINITION PERSISTENT OR RECURRENT DEFICIENCY OR ABSENCE OF SEXUAL FANTASIES AND DESIRE FOR SEXUAL ACTIVITY WITH MARKED DISTRESS OR INTERPERSONAL DIFFICULTY NOT OTHERWISE ACCOUNTED FOR BY A GENERAL MEDICAL OR PSYCHIATRIC CONDITION.
5 ISSWSH DEFINITION MAY BE: PRIMARY OR SECONDARY GENERALIZED OR SITUATIONAL LIFELONG OR ACQUIRED
6 ISSWSH DEFINITION MAY INCLUDE ANY OF THE FOLLOWING: LACK OF MOTIVATION FOR SEXUAL ACTIVITY AS MANIFESTED BY EITHER REDUCED OR ABSENT SPONTANEOUS DESIRE ( SEXUAL THOUGHTS OR FANTASIES) OR REDUCED OR ABSENT REPONSIVE DESIRE TO EROTIC CUES AND STIMULATION OR INABLILITY TO MAINTAIN DESIRE OR INTEREST THROUGH SEXUAL ACTIVITY
7 ISSWSH DEFINITION MAY INCLUDE ANY OF THE FOLLOWING: LOSS OF DESIRE TO INITIATE OR PARTICIPATE IN SEXUAL ACTIVITY, INCLUDING BEHAVIORAL RESPONSES SUCH AS AVOIDANCE OF SITUATIONS THAT COULD LEAD TO SEXUAL ACTIVITY THAT IS NOT SECONDARY TO SEXUAL PAIN DISORDERS, AND IS COMBINED WITH CLINICALLY SIGNIFICANT PERSONAL DISTRESS THAT INCLUDES FRUSTRATION, GRIEF, INCOMPETENCE, LOSS, SADNESS, SORROW OR WORRY.
8 BIO-PSYCHO-SOCIAL MODEL FSD INTERACTION BETWEEN: BIOLOGY INTERPERSONAL RELATIONSHIP PSYCHOLOGY CULTURE
9 FSD INTERACTION
10 HYPOACTIVE SEXUAL DESIRE DISORDER
11 HSDD NEUROENDOCRINE FACTORS MAJOR DETERMINENT OF WOMEN S SEXUAL FUNCTION CENTRAL CONTRIBUTION FROM NEUROTRANSMITTERS SEX STEROIDS EXERT ACTIVATIONAL EFFECTS IN ORDER TO PRIME THE BRAIN
12 HSDD NEUROENDOCRINE BALANCE BETWEEN SEXUAL INHIBITION AND SEXUAL EXCITATION INHIBITORY FACTORS OPIOIDS ENDOCANNABINOIDS SEROTONIN EXCITATORY FACTORS DOPAMINE NE OXYTOCIN MELANACORTINS
13 HSDD HISTORY ARE YOU EXPERIENCING PAIN, AROUSAL AND/OR ORGASMIC PROBLEMS HOW IS YOUR RELATIONSHIP WITH YOUR PARTNER; HOW LONG WHAT DO YOU THINK IS THE ISSUE WHAT WOULD BE DIFFERENT IF I COULD SNAP MY FINGERS AND ALL WOULD BE BETTER
14 HSDD HISTORY ACQUIRED VS GENERALIZED HOW LONG HAS IT BEEN A PROBLEM ANY RECENT LIFE EVENTS ANY TRIGGERS FOR SEXUAL EXCITEMENT HOW MUCH DOES IT DISTRESS YOU HOW OFTEN DO YOU ENGAGE IN SEXUAL ACTIVITY
15 PSYCHIATRIC HSDD ETIOLOGY MOOD DISORDERS ANXIETY/DEPRESSION PSYCHOSIS CVD/HTN NEUROLOGICAL DISORDERS UROLOGIC PROBLEMS STI S
16 HSDD ETIOLOGY GYNECOLOGIC DISORDERS PELVIC FLOOR POSTPARTUM MENOPAUSE ENDOCRINE DISORDERS DIABETES THYROID HYPERPROLACTENEMIA ANDROGEN DEFICIENCY OTHER RA CANCER
17 HSDD ETIOLOGY POOR BODY IMAGE PRIVACY STRESS FATIGUE MEDICATIONS
18 HSSD MEDICATIONS PSYCHOTROPIC MEDICATIONS: SSRI, SRNI, TRICYCLIC MOOD STABLIZERS ANTIPSYCHOTICS BENZODIAZAPEMS ANTISEIZURE ANTIHYPERTINESIVE MEDICATIONS: BETA BLOCKERS ALPHA BLOCKERS DIURETICS
19 HSDD MEDICATIONS CARDIOVASCULAR MEDICATIONS: LIPID LOWERING DRUGS DIGOXIN HORMONES ORAL CONTRACEPTIVES ESTROGENS PROGESTERONE ANTI-ANDROGENS GNRH AGONISTS OTHER HISTAMINE H-2 RECEPTOR BLOCKERS OPIOIDS NSAIDS
20 HSDD NON-HORMONAL TREATMENTS FLIBANSERIN BUPROPRION BREMELANOTIDE LYBRIDO/LYBRIDOS
21 HSDD FLIBANSERIN 5-HT 1A AGONIST AND 5-HT2A ANTAGONIST BINDS WITH MODERATE AFFINITY TO DOPAMINE D4 RECEPTORS INHIBITS SEROTONONERGIC ACTIVITY AND INCREASES DOPAMINERGIC ACTIVITY ALSO INCREASES NE BY DECREASING 5-HT LEVELS
22 HSDD FLIBANSERIN SIGNIFICANT IMPROVEMENT IN THE NUMBER OF SSE S IMPROVEMENT IN LEVEL OF SEXUAL DESIRE DECREASE IN DISTRESS APPROVED FOR PREMENOPAUSAL WOMEN
23 HSDD FLIBANSERIN (ADDYI) ADVERSE EVENTS (<10%) NAUSEA DIZZYNESS FATIGUE SOMNOLENCE SYNCOPE
24 HSDD FLIBANSERIN (ADDYI) ALCOHOL INTERACTION NO ALCOHOL CONSUMPTION DUE TO HYPOTENSION AND SYNCOPE PATIENTS MUST SIGN AN AGREEMENT INTERACTION WAS NOT SEEN IN PHASE III TRIALS BUT WAS REPORTED IN A SEPARATE ALCOHOL INTERACTION STUDY DOSING: 100 MG AT BEDTIME REVALUATE AT 8 WEEKS, IF NO CHANGE THEN STOP MEDICATION
25 HSDD BUPROPRIAN ANTIDEPRESSENT INHIBITS UPTAKE OF NE AND DA NO SEROTONERGIC EFFECT MILD TO MODERATE INCREASE IN DESIRE TRAZODONE ANTIDEPRESSENT 5-HT RECEPTOR ANTAGONISTS AND REUPTAKE INHIBITOR MILD INCREASES IN DESIRE
26 HSDD BUSPIRONE ANTIANXIETY PARTIAL AGONIST FOR 5-HT1A RECEPTORS APOMORPHINE CENTRAL ACTING DOPAMINE AGONIST
27 HSDD BREMELANOTIDE MELANOCORTINS MODULATE SEXUAL BEHAVIOR AT THE HYPOTHALAMIC LEVEL ANALOG OF MSH AGONISTIC AT MELANOCORTIN 3 AND 4 RECEPTORS AIDS IN TRANSLATING SEXUAL CUES INTO GENITAL RESPONSE CONFER BENEFITS ON DESIRE AND AROUSAL
28 HSDD BREMELANOTIDE PHASE II TRIALS SIGNIFICANT IMPROVEMENT IN DESIRE, AROUSAL,SSE S, ORGASM AND DECREASED DISTRESS PHASE III TRIALS ONGOING SUBCUTANEOUS SELF INJECTED
29 HSDD LYBRIDO/LYBRIDOS 2 SUBGROUPS: WOMEN WHOSE HSDD ARE TO INSENSITIVE BRAIN SYSTEMS FOR SEXUAL CUES WOMEN WHOSE HSDD DUE TO INCREASE INHIBTORY MECHANISMS
30 HSDD LYBRIDO/LYBRIDOS LOW SENSITIVITY TO SEXUAL CUES TESTOSTERONE SUBLINGUAL ( 0.5 MG) PDE5i (SILDENIFIL 50 MG) HIGH SEXUAL INHIBITION TESTOSTERONE SUBLINGUAL (0.5 MG) BUSPIRONE (10 MG)
31 SEXUAL PAIN
32 SEXUAL PAIN VULVOVAGINAL ATROPHY PART OF GSM ETIOLOGY LACK OF ESTROGEN MENOPAUSE AI S CHEMOTHERAPY RADIATION
33 VVA PATHOPHYSIOLOGY DECREASE IN SUPERFICIAL CELLS INCREASE PARABASAL CELLS DECREASE GLYCOGEN DECREASE IN LACTIC ACID INCREASE ph
34 VVA SYMPTOMS DRYNESS PAIN BLEEDING LACERATIONS FISSURES HSDD AROUSAL/ORGASM DYSFUNCTION
35 VVA CLINICAL APPEARNCE VULVAR PALLOR LABIAL RESORPTION URETHRAL TELESCOPING NARROWED INTROITUS VAGINAL PALLOR LOSS OF RUGAE INCREASED ph DECREASED ELASTICITY
36 VVA TREATMENT-HORMONAL ESTROGENS: ESTRACE CREAM PREMARIN CREAM ESTRADIOL TABLETS ESTRING
37 VVA TREATMENTS HORMONAL ESTRADIOL CREAM 1-2 GRAMS DAILY FOR 2 WEEKS THEN TWICE A WEEK PREMARIN CREAM CONJUGATED ESTROGENS GRAMS DAILY FOR 2 WEEKS THEN TWICE A WEEK SYSTEMIC ABSORBTION
38 VVA TREATMENTS HORMONAL ESTRADIOL TABLETS 10 mcg-insert DAILY FOR 2 WEEKS THEN TWICE A WEEK SYSTEMIC ABSORBTION NOT MESSY ESTRING ESTRADIOL EVERY 3 MONTHS
39 VVA TREATMENT HORMONAL CONTRAINDICATIONS: UNDIAGNOSED VAGINAL BLEEDING CURRENT/PAST HISTORY BREAST CANCER ESTROGEN-DEPENDENT CANCER VTE HEPATIC IMPAIRMENT PREGANCY PROTEIN C OR S DEFICIENCY THROMBOPHILIC DISORDER ARTERIAL THROMBOEMBOLISM W/I 12 MTH
40 VVA TREATMENT NON-HORMONAL OSPHENA: SERM AGONISTIC ON VAGINAL TISSUE AND ENDOMETRIUM EFFECT ON BREAST DAILY ORAL PILL
41 VVA TREATMENT NON-HORMONAL OPSHENA-CONTRAINDICATIONS UNDIAGNOSED VAGINAL BLEEDING CURRENT OR PAST HX BREAST CANCER ESTROGEN DEPENDENT CA OR HX VTE ARTERIAL THROMBOEMBOLISM PREGNANCY
42 VVA TREATMENT NON-HORMONAL INTRAROSA (PRASTERONE) DHEA CONVERTS TO ESTRADIOL AND TESTOSTERONE NO SYSTEMIC ABSORBTION NO EFFECT ON ENDOMETRIUM DAILY INTRAVAGINAL TABLET Q HS
43 VVA TREATMENT NON-HORMONAL INTRAROSA-CONTRAINDICATIONS UNDIAGNOSED ABNORMAL GENITAL BLEEDING CAUTIONARY USE IN PATIENTS WITH PAST OR CURRENT HISTORY OF BREAST CANCER
44 FEMALE SEXUAL AROUSAL DISORDER
45 FEMALE SEXUAL AROUSAL DISORDER SUBJECTIVE VS. OBJECTIVE SUBJECTIVE REFERS TO A WOMAN S PERCEPTION REGARDING HER GENITAL RESPONSE OBJECTIVE REFERS TO THE PHYSIOLOGIC GENITAL AROUSAL THAT OCCURS SUCH AS VAGINAL LUBRICATION AND VASOCONGESTION LOW CONCORDANCE
46 FSAD LOW CONCORDANCE VAGINAL PHOTPLETHYSMOGRAPHY EXTERNAL GENITALIA
47 FSAD ASSESSMENT OF SUBJECTIVE AROUSAL HOW OFTEN DO YOU NOTICE YOURSELF BEING SEXUALLY AROUSED? WHAT SITUATITONS HELP YOU FEEL EXCITED? DO YOU HAVE SEXUAL FANTASIES? IS THERE A CERTAIN SCENARIO IN A FANTASY THAT AROUSES YOU? HOW EASY IS IT TO GET AROUSED WITH YOUR CURRENT PARTNER?
48 FSAD ASSESSMENT OF SUBJECTIVE AROUSAL WHAT SENSATIONS DO YOU NOTICE IN YOUR GENITAL AREA WHEN YOU GET EXCITED? DO YOU HAVE EROTIC DREAMS? DO YOU BELIEVE YOUR SEXUAL EXCITEMENT IS HEALTHY? WHAT DO YOU THINK IS INTERFERING WITH YOUR AROUSAL?
49 FSAD PSYCHOSOCIAL FACTORS DISTRACTIONS STRESS ATTACHMENT AND MOOD DISORDER AGING AND MENOPAUSE CULTURAL /RELIGIOUS FACTORS RELATIONSHIP ISSUES SEXUAL TRAUMA
50 FSAD TREATMENTS HORMONAL THERAPY TESTOSTERONE IMPROVES SEXUAL AROUSAL AND DESIRE DIRECT EFFECT ON VAGINA AND GENITAL STRUCTURES INDEPENDENT OF ESTROGEN NO APRROVED FORMULATION FOR WOMEN SERUM LEVELS DO NOT NECESSARILY CORRELATE WITH EFFECT
51 TIBOLONE FSAD TREATMENT HORMONAL THERAPY SELECTIVE TISSUE ESTROGENIC ACTIVITY REGULATOR ENHANCES MOOD, LIBIDO, AROUSAL ACTS LIKE ESTROGEN ON BRAIN,VAGINA AND BONE BUT NOT ON BREAST,UTERUS 19 NORTESTOSTERONE DERIVATIVE METABOLIZED INTO 3 METABOLITES 2 WHICH ARE ESTROGENIC 1 PROGESTIONAL AND ANDROGENIC EFFECT
52 FSAD TREATMENT SO WHY DO WE NOT USE TIBOLONE?
53 FSAD TREATMENT BECAUSE AS WITH SO MANY OTHER DRUGS FOR FSD, IT IS NOT APPROVED BY THE FDA FOR DISTRIBUTION IN THE U.S.
54 FSAD TREATMENT NON-HORMONAL THERAPY PHOSPHODIESTERASE TYPE 5 INHIBITORS INCREASE BLOOD FLOW TO CLITORIS AND VAGINA INCREASES AROUSAL?? DATA LACKING IN EFFICACY MAYBE SECONDARY TO DISCORDANCE BETWEEN SUBJECTIVE AND GENITAL AROUSAL INCREASES PHYSIOLOGIC BUT NOT SUBJECTIVE AROUSAL
55 PDE5i FSAD TREATMENT NON-HORMONAL MAY BE OF BENEFIT IN PREMENOPAUSAL WOMEN WITH MEDICAL CONDITIONS THAT EFFECT NEUROVASCULAR COMPONENTS TYPE 1 DM SPINAL CORD INJURIES MS SSRI USE
56 L-ARGININE FSAD TREATMENT NON-HORMONAL PRECURSOR TO NITRIC OXIDE DOUBLE BLINDED STUDY WITH YOHIMBINE (ADRENERGIC ANTAGONIST) INCREASE VAGINAL FLOW NO EFFECT ON SUBJECTIVE AROUSAL
57 FSAD TREATMENT NON-HORMONAL ARGINMAX L-ARGININE,GINSENG, GINKGO,DAMIANA,VITAMINS A,C,E,B COMPLEX,MINERALS, IRON CALCIUM AND ZINC DOUBLE BLINDED PLACEBO TRIAL INCREASED CLITORAL SENSATION,DESIRE, ORGASM FREQUENCY WITH NO SIGNIFICANT SIDE EFFECTS
58 FSAD TREATMENTS NON-HORMONAL DOPAMINE AGONISTS OPEN LABEL, DOSE ESCALATING STUDY SUBLINGUAL APOMORPHINE INCREASE IN HSDD, FSAD AE-NAUSEA, DIZZYNESS BUPROPRION COCHRANE REVIEW-SSRI INDUCED FSD 5 RANDOMIZED TRIALS-579 WOMEN IMPROVEMENT IN SEXUAL RATING SCORE OXYTOCIN NEUROPEPTIDE DOUBLE BLINDED,PLACEBO CONTROLLED INTRANASAL ADMINISTRATION IMPROVENT IN INTENSITY OF ORGASM AND CONTENTMENT
59 ZESTRA FSAD TREATMENT NON-HORMANAL OTC MASSAGE OIL-BORAGE SEED OIL, NAGELICA EXTRACT, EVENING PRIMROSIE, COLEUS EXTRACT, VITAMINS C AND E SMALL (N=10) RANDOMIZED, DOUBLE BLINDED PLACEBO CONTROLLED STUDY INCREASE IN SATISFACTION, ORGASM, AROUSAL DESIRE IN WOMEN WITH/WITHOUT FSAD
60 FSAD TREATMENT MECHANICAL VIBRATORS EROS BATTERY OPERATED DEVICE APPLIES VACUUM TO CLITORIS INCREASES BLOOD FLOW TO ERECTILE CHAMBERS OF THE CLITORIS AND THE VULVA FIERA AROUSER FIRST WEARABLE INTIMACY ENHANCER SMALL RECHARGEABLE BATTERY VIBRATING DEVICE ADHERES TO CLITORIS BY GENTLE SUCTION WORN IN PREPARATION FOR SEXUAL ACTIVITY
61 FEMALE ORGASMIC DISORDER
62 FEMALE ORGASMIC DISORDER ABSENCE OF ORGASM DIFFICULTY REACHING ORGASM DECREASED INTENSITY LIFELONG/ACQUIRED ISOLATED TO SPECIFIC PARTNERS, SITUATIONS ACTIVITIES DISTRESS
63 FOD GENERALLY ASSOCIATED WITH ONE OTHER FACTOR IN FSD RULED OUT IF BETTER EXPLAINED BY MEDICATION, ILLNESS, PARTNER
64 FOD PRIMARY ANORGASMIA SITUATIONAL ANORGASMIA
65 FOD VAGINAL VS. CLITORAL DSM-V DE-PATHOLIGIZED CLITORAL AND CONSIDERED A NORMAL VARIATION AT LEAST ONE THIRD OF POPULATION CANNOT EXPERIENCE VAGINAL ORGASM MOST CAN REACH ORGASM THROUGH MASTURBATION, ORGASM WITH PARTNERED ACTIVITY LESS CONSISTENT
66 FOD ASSESSMENT NATURE, ONSET, DURATION OTHER SEXUAL ISSUES DEGREE OF DISTRESS RELATIONSHIP ISSUES MASTURBATION GENERALIZED/SITUATIONAL PRIMARY/SECONDARY
67 FOD RISK FACTORS LOWER SOCIOECONOMIC CLASS POOR PHYSICAL HEALTH POOR MENTAL HEALTH RESTRICTIVE ATTITUDES AND BELIEFS LESS SEX EDUCATION PRIMARY YOUNGER LESS EXPERIENCE UNREALISTIC EXPECTATIONS SECONDARY ASK ABOUT CONDITIONS WHERE THEY WERE ORGASMIC RULE OUT CONTEXTUAL FACTORS, INADEQUATE PARTNER STIMULATION,PHYSIOLOGIC FACTORS
68 FOD TREATMENTS EDUCATION SEXUAL THERAPY DIRECTED MASTURBATION SENSATE FOCUS VIBRATORS EROTICA
69 FOD TREATMENTS PATHOPHYSIOLOGY CONTEXT OF AROUSAL AND DESIRE DISORDERS EFFERENT PART OF THE ORGASMIC REFLEX NORADRENERGIC, CHOLINERGIC ACTIVITY ENZYMATIC ACTION ON GUANOSINE MONOPHOSPHATE SYSTEM AFFERENT PART OF THE ORGASMIC REFLEX INCREASES INTENSITY OF STIMULUS INCREASES THE RECEPTIVITY OF GENITALIA BY INCREASING BLOOD FLOW AND STRUCTURAL INTEGRITY
70 FOD TREATMENTS PDE 5i MIXED RESULTS PHYSIOLOGIC STUDIES SHOW INCREASE VASOCONGESTION SYSTEMIC ESTROGEN/TESTOSTERONE INCREASES AROUSAL, DESIRE,ORGASM IN WOMEN WITH OOPHERECTOMY RECEPTIVE CNS EFFECTS,VVA IMPROVEMENT, EXCITATORY EFFECT OF TESTOSTERONE ON LIMBIC SYSTEM TIBOLONE
71 FOD TREATMENTS CONTEXT OF SUFFICIENT AROUSAL FEW STUDIES DESCRIBED AS A STOP IN THE INCREASING INTENSITY OF AROUSAL TOWARD ORGASM GOAL- INTENSIFY THE STIMULATION IN STRENGTH, FREQUENCY
72 FOD TREATMENT OXYTOCIN FACILTATES MUSCLE CONTRACTION EROTICA FIERA EROS VIBRATORS
73 CONCLUSION ACKNOWLEDGE THAT SEXUAL DYSFUNCTION CAUSES SIGNIFICANT DISTRESS AND IS NOT A LIFESTYLE ISSUE REALIZE THAT WE MUST UTILIZE BIOPSYCHOSOCIAL APPROACH TO DEAL WITH FSD MUST HAVE DISCUSSIONS WITH OUR PATIENTS REGARDING FSD
74 THANK YOU
Psykiatri PCK/Sexologisk Klinik Medication for Female Sexual Dysfunction - where are we?
Medication for Female Sexual Dysfunction - where are we? Annamaria Giraldi, Professor, MD, PHD Sexological Clinic Copenhagen, Denmark Disclosures Eli Lilly - lecturer Boehringer advisory board Pfizer -
More informationSexual dysfunction: Is it all about hormones?
Sexual dysfunction: Is it all about hormones? Angelica Lindén Hirschberg, MD, PhD, Professor Department of Women s and Children s Health, Karolinska Institutet and Karolinska University Hospital, Stockholm,
More informationErin E. Stevens, MD Chair, Department of Gynecologic Oncology Billings Clinic Cancer Center January 18, 2017
Erin E. Stevens, MD Chair, Department of Gynecologic Oncology Billings Clinic Cancer Center January 18, 2017 Objectives Define what's normal Define female sexual dysfunction Identify the causes of female
More informationUpdating the Female Nomenclature: ICSM, ISSWSH, and ICD-11 Classification. Sharon J. Parish, MD, IF, NCMP 2017 Annual Scientific Program May 12, 2017
Updating the Female Nomenclature: ICSM, ISSWSH, and ICD-11 Classification Sharon J. Parish, MD, IF, NCMP 2017 Annual Scientific Program May 12, 2017 Disclosures Advisory Board Palatin, Valeant Speaker
More informationFEMALE SEXUAL HEALTH 3/12/2018 DEFINITIONS- HYPOACTIVE SEXUAL DESIRE DISORDER DEFINITIONS: FEMALE GENITAL AROUSAL DISORDER
DEFINITIONS- HYPOACTIVE SEXUAL DESIRE DISORDER FEMALE SEXUAL HEALTH Manifests as any of the following: Lack of motivation for sexual activity as manifested by either: Reduced or absent spontaneous desire
More informationDr. Maliheh Keshvari
1 Dr. Maliheh Keshvari Assistant professor of Urology Fellowship in Female Urology Mashhad University of Medical Sciences 2 Female Sexual Function and Dysfunction 3 It was not until recently that urologists
More informationHypoactive Sexual Desire Disorder: Advances in Diagnosis and Treatment
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationUnderstanding the Spectrum of Female Sexual Dysfunction
. Understanding the Spectrum of Female Sexual Dysfunction Bruce Kessel, MD Chair Jeanne Leventhal Alexander, MD; Sheila Bolour, MD; Mark Elliott, PhD; Lori Futterman, RN, PhD; Jannet Huang, MD; Lee Shulman,
More informationSexuality. The Pharmacologic Treatment of Female Sexual Dysfunction: Future Reality or Wishful Thinking? Risks of Opening the Medicine Cabinet
5 th Annual Meeting of the North American Menopause Society October 5, 4 Washington, DC Low Libido at Midlife: Will the Answer Ever Be in Our Medicine Cabinets? The Pharmacologic Treatment of Female Sexual
More informationSexuality After the Diagnosis of Ovarian Cancer
Sexuality After the Diagnosis of Ovarian Cancer June La Valleur, MD, FACOG, Sexual Health Counselor Associate Professor, Ret., University of Minnesota Medical School Sexual Health Consultant at Skyhill
More informationNivedita Dhar M.D. Wayne State University April 25, 2013
Female Sexual Dysfunction Nivedita Dhar M.D. Wayne State University April 25, 2013 Outline Define Sexual Health and Wellness and discuss how it is unique to each individual Discuss the current terminology
More informationNew Treatments for Vaginal Health. Sarah Azad, MD El Camino Women s Medical Group
New Treatments for Vaginal Health There s Hope Sarah Azad, MD El Camino Women s Medical Group The Genitrourinary Syndrome of Menopause (GSM) Problems with genital health secondary to the changes that occur
More informationOutline. Do Women Care about Sex? 3/22/2016. Aging and sexuality: More than just menopause. Sexual Health is. Definitions and Epidemiology
Outline Definitions and Epidemiology Aging and sexuality: More than just menopause Physiology, Definitions, Dysfunction Tami Rowen MD MS Assistant Professor UCSF Department of ObGyn&RS Physiology of Female
More informationSexuality and Sexual Dysfunction in Women
Sexuality and Sexual Dysfunction in Women Denise M.S. Willers, MD Associate Professor of Obstetrics and Gynecology Washington University School of Medicine Disclosures No financial disclosures to make
More informationFemale Sexuality Sheryl A. Kingsberg, Ph.D.
Female Sexuality Sheryl A. Kingsberg, Ph.D. Professor of Reproductive Biology Case Western Reserve University School of Medicine Chief, Division of Behavioral Medicine Department of OB/GYN University Hospitals
More informationAddyi (flibanserin) When Policy Topic is covered Coverage of Addyi is recommended in those who meet the following criteria:
Addyi (flibanserin) Policy Number: 5.01.605 Last Review: 10/2018 Origination: 10/2015 Next Review: 10/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Addyi when
More informationQuick Study: Sex Therapy
Quick Study: Sex Therapy Sexual Dysfunction: Difficulty experienced by an individual or couple during the stages of normal sexual activity including physical pleasure, desire, arousal, or orgasm. Assessing
More informationLeslie R. Schover, PhD Department of Behavioral Science
Causes and Treatments of Low Sexual Desire in Breast Cancer Survivors Leslie R. Schover, PhD Department of Behavioral Science IMPORTANCE OF SEX TO BREAST CANCER SURVIVORS Livestrong 2006 Post-Treatment
More information9/30/2016. Data and Women s Preferences Should Inform the Treatment of Hypoactive Sexual Desire Disorder: The Case for Pharmacologic Agents
Data and Women s Preferences Should Inform the Treatment of Hypoactive Sexual Desire Disorder: The Case for Pharmacologic Agents Sources of Evidence for Physiological Mechanisms Modulating Sexual Desire
More informationInnovations in the Management of Dyspareunia
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationManagement of Menopausal Symptoms
Management of Menopausal Symptoms Tammie Koehler DO, FACOG 1 Menopause Permanent cessation of menstruation that occurs after the loss of ovarian activity Determined to have occurred after 1 full year of
More informationDr.Anjalakshi Chandrasekar M.D.,D.G.O.,Ph.D Prof & HOD Dept.of Obstetrics & Gynaecology S.R.M.Medical College Potheri
Dr.Anjalakshi Chandrasekar M.D.,D.G.O.,Ph.D Prof & HOD Dept.of Obstetrics & Gynaecology S.R.M.Medical College Potheri Adolescent Adolescence is defined as Universal phenomenon of human development characterised
More informationOutline. Clinic Visit: Mrs. Jones 3/10/2015
Outline Kim O Connor, MD, FACP Associate Professor University of Washington General Internal Medicine Sexual Response Cycle Categories of Female Sexual Dysfunction Biopsychosocial influences History Evaluation
More informationThe Impact of Mental Illness on Sexual Dysfunction
Balon R (ed): Sexual Dysfunction. The Brain-Body Connection. Adv Psychosom Med. Basel, Karger, 2008, vol 29, pp 89 106 The Impact of Mental Illness on Sexual Dysfunction Zvi Zemishlany Abraham Weizman
More informationSex Cells The effect of hormones on peri- and post- menopausal female sexuality Dr. Cathy Caron November 24, 2011
Sex Cells The effect of hormones on peri- and post- menopausal female sexuality Dr. Cathy Caron November 24, 2011 Is sex over at menopause? Older adults are having sex 51% of women ages 50 to 59 report
More informationDesire for Desire. Michael L Krychman MD
Desire for Desire Michael L Krychman MD Executive Director of the Southern California Center for Sexual Health and Survivorship Medicine AASECT Certified Sexual Counselor Associate Clinical Professor UCI
More informationManaging the Patient with Erectile Dysfunction: What Would You Do?
Managing the Patient with Erectile Dysfunction: What Would You Do? Florida A & M University College of Pharmacy and Pharmaceutical Sciences 42 nd Annual Clinical Symposium Wayne A. Sampson, M.D. Cross
More informationACTIVITY DISCLAIMER DISCLOSURE. Associated Session(s) Learning Objectives. Female Sexual Dysfunction: Demystifying the Secret Garden
ACTIVITY DISCLAIMER Female Sexual Dysfunction: Demystifying the Secret Garden Phyllis MacGilvray, MD, FAAFP The material presented here is being made available by the American Academy of Family Physicians
More informationWomen's Cancer & Sexuality Diljeet K. Singh, MD, DrPH CANCER SURVIVOR DAY
Women's Cancer & Sexuality Diljeet K. Singh, MD, DrPH CANCER SURVIVOR DAY Explicit diagrams & anatomy drawings will be used in this lecture Specific treatment techniques will be discussed for sexual problems
More informationMayo Clin Proc, July 2002, Vol 77 Female Sexual Dysfunction Sexual pain disorder: the persistent or recurrent genital pain associated with non
698 Concise Review for Clinicians Female Sexual Dysfunction DEBORAH J. LIGHTNER, MD Female sexual dysfunction (FSD) was recently recognized as arising from multiple organic etiologies; it is not primarily
More informationThere are a variety of ways to address VVA. Keep yourself healthy, avoid irritants to the vulva and vagina, and use moisturizers and lubricants.
What is VulvoVaginal Atrophy? VulvoVaginal Atrophy, or VVA for short, is also called genitourinary syndrome of menopause. VVA is a condition where the skin of the vagina and vulva becomes thin, dry and
More informationResilient Intimacy. Richa Sood, M.D.
Resilient Intimacy Richa Sood, M.D. Disclosures No financial conflicts My specialty is Female Sexual Dysfunction Common Questions What is normal sexuality, and how does it change with medical illness?
More informationDISCLOSURES. I have no disclosures, but if I discover a potion for improving sex drive for women, I will let someone pay me for my secrets.
DISCLOSURES I have no disclosures, but if I discover a potion for improving sex drive for women, I will let someone pay me for my secrets. OBJECTIVES Define libido Recognize medications and medical conditions
More informationMale Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: gmail.
RESEARCH ARTICLE Open Access Male Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: drsujita@gmail.com; saranya296@ gmail.com Full list of author information
More informationParticipant Objectives
Intimacy after a Cancer Diagnosis Jennifer Currin- McCulloch, LMSW,OSW-C Curtis and Elizabeth Anderson Cancer Institute Participant Objectives Describe sexual barriers that individuals with cancer may
More informationSexual problems- some basic information
Sexual Problems 1 Soheil A. Hanjani, MD, FACOG, FACS Obstetrics & Gynecology 830 Oak Street Brockton, MA 02301 (508) 583-4961 Fax (508) 583-4732 Soheil.Hanjani@Steward.org www.hanjanimd.com Sexual problems-
More informationMenopause Symptoms and Management: After Breast Cancer
Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a
More informationBody image and sexuality issues after surgery or cancer
Body image and sexuality issues after surgery or cancer Sharon L. Bober, Ph.D. Director, Sexual Health Program Perini Family Survivors Center Dana-Farber Cancer Institute June 26, 2010 Why doesn t sex
More informationDisease (diabetic neuropathy, multiple sclerosis, tumors, and, rarely, tertiary syphilis)
COURSES ARTICLE - THERAPYTOOLS.US Individual Planning: A Treatment Plan Overview for Adult Men with Sexual Performance Problems Individual Planning: A Treatment Plan Overview for Adult Men with Sexual
More informationSexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist
Sexual dysfunction of chronic kidney disease Razieh salehian.md psychiatrist Disturbances in sexual function are a common feature of chronic renal failure. Sexual dysfunction is inversely associated with
More informationPresentation 10 Feb 2, 2019
Addressing Sexual Relationship Concerns for the Patient Treated for Cancer 2019 BREAST HEALTH: A TEAM APPROACH 2/2/2019 SARAH JAX, MA, APRN, AOCNP MINNESOTA ONCOLOGY - PLYMOUTH Objectives Discuss causes
More informationOpening the Door to Intimacy. Carolynn Peterson, RN, MSN, AOCN
Opening the Door to Intimacy Carolynn Peterson, RN, MSN, AOCN What is the largest sex organ in humans? Ways That Cancer or Its Treatment Can Affect Your Sexuality: Physical ability to give and receive
More informationOBSTETRICS & GYNECOLOGY
JANUARY 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Female Sexual Arousal
More informationFlibanserin for Hypoactive Sexual Desire Disorder: Can We Bring Back that Loving Feeling?
Flibanserin for Hypoactive Sexual Desire Disorder: Can We Bring Back that Loving Feeling? Lori D. Watkins, Pharm.D PGY1 Pharmacy Practice Resident Methodist Hospital, San Antonio, Texas Division of Pharmacotherapy,
More informationOBSTETRICS & GYNECOLOGY
AUGUST 2011 NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: BHRT for Menopause
More informationPSYCHOLOGICAL TREATMENT FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN MEN AND WOMEN
PSYCHOLOGICAL TREATMENT FOR HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN MEN AND WOMEN MARITA McCABE PhD FAPS DIRECTOR INSTITUTE FOR HEALTH AND AGEING SMSNA 207 Annual Scientific Meeting May 2, 207 Boston,
More informationWomen s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School
Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help
More informationSexual Health in Older Adults
Sexual Health in Older Adults Lauren Carpenter, MD UW Division of Gerontology and Geriatric Medicine VA Puget Sound Geriatrics & Extended Care Objectives > Identify barriers to addressing sexual health
More informationProcess of Aging. Manifestation of Estrogen and/or Androgen Loss: Symptoms Over Time. Estrogen Decrease and Its Impact on Sexual Functioning
Impact of Vulvovaginal Atrophy on Quality of Life and Sexuality Process of Aging physical health sexual activity Sexual function and aging desire androgen levels Michael L. Krychman MD Executive Director
More informationWomen s Intimacy, Sexuality and Relationship Issues After Cancer
Women s Intimacy, Sexuality and Relationship Issues After Cancer Sylvie Aubin, Ph.D. Segal Cancer Centre Jewish General Hospital McGill University Objectives Acknowledge changes in intimacy and sexuality
More informationDyspareunia: Best Practices in Counseling, Diagnosis, and Therapy
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationSexological aspects of genital pain
Sexological aspects of genital pain Annamaria Giraldi, professor, MD, PHD Sexological Clinic, Psychiatric Centre Copenhagen 1 Disclosures Speaker: Eli Lilly, Pfizer Consultant: Eli Lilly,Palatin 2 Agenda
More informationTherapy and Sexual Health
Menopausal hormone therapy and sexual health Earn 3 CPD Points online Menopausal Hormone Therapy and Sexual Health Key messages Dr Tobie De Villiers Consultant Gynaecologist Panorama MediClinic Department
More informationAmy Siston, Ph.D. July 9, 2017
Amy Siston, Ph.D. July 9, 2017 Prevalence of Sexual Dysfunction Non-Cancer Population Ovarian Cancer Population 43% 30-100% Common Sexual Issues DESIRE: 25-59% no/low sexual desire AROUSAL: 24-60% difficulty
More informationMALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
MALE SEXUAL DYSFUNCTION Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara DEFINITION The inability to achieve a satisfactory sexual relationship May involve : - inadequacy
More informationWomen s Sexual Interest/Desire Disorder : Implications of New Definition
Women s Sexual Interest/Desire Disorder : Implications of New Definition Rosemary Basson MD FRCP(UK) Vancouver General Hospital University of British Columbia Vancouver, Canada 1 New Model of Sex Response
More informationManagement of Menopausal Symptoms in Patients with Breast Cancer. Mike Dixon Edinburgh Breast Unit
Management of Menopausal Symptoms in Patients with Breast Cancer Mike Dixon Edinburgh Breast Unit Menopausal symptoms have a major impact on Quality of Life Variety of Symptoms associated with the Menopause
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More informationHypoactive Sexual Desire Disorder: Assessment, Diagnosis and Treatments
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationOB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,
More informationMENOPAUSAL HORMONE THERAPY 2016
MENOPAUSAL HORMONE THERAPY 2016 Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA NICE provides the National Health Service advice on effective, good value healthcare.
More informationSexual dysfunction in women with cancer: Navigating intimacy and intercourse between women and their partners
Sexual dysfunction in women with cancer: Navigating intimacy and intercourse between women and their partners Don S. Dizon, MD, FACP Clinical Co-Director, Gynecologic Oncology Founder and Director, The
More informationInterventions to Address Sexual Problems in People with Cancer
A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Interventions to Address Sexual Problems in People with Cancer L. Barbera, C. Zwaal, D. Elterman, K. McPherson,
More informationDESIRE DISORDERS : ENDOCRINOLOGICAL ETIOLOGIES & TREATMENT PERSPECTIVES. Dr Michèle BUVAT-HERBAUT 97 avenue Marx Dormoy LILLE ( France )
DESIRE DISORDERS : ENDOCRINOLOGICAL ETIOLOGIES & TREATMENT PERSPECTIVES Dr Michèle BUVAT-HERBAUT 97 avenue Marx Dormoy 59000 LILLE ( France ) HYPO ACTIVE SEXUAL DESIRE IN WOMEN Until 6 years ago,the definition
More informationManagement of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*
Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine
More informationErectile Dysfunction Medical Treatment
1 Erectile Dysfunction Medical Treatment Alireza Ghoreifi Assistant of Urology Mashhad University of Medical Sciences March 2012 2 Treatment of ED Unknown cases of ED First-line therapy Second-line therapy
More informationSexual Health and Dysfunction in the Elderly. Nadya S. Dávila Lourido, MD September 28, 2018
Sexual Health and Dysfunction in the Elderly Nadya S. Dávila Lourido, MD September 28, 2018 Objectives: To review physiologic changes associated with aging To discuss the importance of the history and
More informationFemale sexual dysfunction
Drug therapy applied to sexuality Impact of POP surgery on female sexuality G. Willy Davila, MD Department of Gynecology Urogynecology/Reconstructive Pelvic Surgery Cleveland Clinic Florida Weston/Ft.
More informationThis article provides a review of the past and current literature on the neurobiology of
The Neurobiology of Sexual Function Cindy M. Meston, PhD; Penny F. Frohlich, MA NEWS AND VIEWS This article provides a review of the past and current literature on the neurobiology of sexual function.
More informationSexual and Gender Identity Disorders
Sexual and Gender Identity Disorders This section contains the Sexual Dysfunctions, the Paraphilias, and the Gender Identity Disorders. The Sexual Dysfunctions are characterized by disturbance in sexual
More informationWinning the War on Women s Cancer Sexual Health & Survivorship
Winning the War on Women s Cancer Sexual Health & Survivorship Tami Serene Rowen MD MS Assistant Professor Division of Obstetrics, Gynecology & Gynecologic subspecialties Lee-may Chen, MD Director, Division
More informationSexual Devices: Clitoral Stimulator, Dilators and Vibrators
Sexual Devices: Clitoral Stimulator, Dilators and Vibrators Michael L. Krychman MD Associate Clinical Attending UCI Irvine, CA Executive Director Southern California Center for Sexual Health and Survivorship
More informationEvidence Based Approach to Low Libido in Women
Evidence Based Approach to Low Libido in Women Nicole Cirino MD, CST, IF Associate Professor, Department of Psychiatry and OB/GYN Reproductive Psychiatrist AASECT Certified Sex Therapist Division Chief,
More informationSouthern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3
The WISDOM survey: Physicians Level of Comfort Prescribing Treatment for Vulvar and Vaginal Atrophy (VVA) Symptoms in Women with a Predisposition or History of Breast Cancer Lisa Larkin, MD 1 ; Michael
More informationCHAPTER 11: SEXUAL AND GENDER PROBLEMS KEY TERMS
CHAPTER 11: SEXUAL AND GENDER PROBLEMS KEY TERMS Androgens The most important of the male hormones. Unusual sexual behaviour, such as impulsive sexual offending involving non-consenting others, may be
More informationTOPICS COVERED. Male Sexuality. Female Sexuality. Ø Age-Associated Changes Ø Physiology, Evaluation and Treatment of Erectile Dysfunction
SEXUALITY 1 TOPICS COVERED 2 Male Sexuality Ø Age-Associated Changes Ø Physiology, Evaluation and Treatment of Erectile Dysfunction Female Sexuality Ø Age-Associated Changes Ø Evaluation and Treatment
More informationYear: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy
Year: 2013 - Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy By: Dr David W Sturdee, Immediate past President International Menopause Society and Hon Consultant Gynaecologist, Solihull
More informationMENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?
MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early
More informationSexual Health: What s New in 2016
Sexual Health: What s New in 2016 Financial Disclosures Husband full time employee Genomic Health No material in this presentation relates to this company Tami Serene Rowen Assistant Professor UCSF Department
More information2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK
2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail
More informationDISORDER DESIRE IN WOMEN
FEMALE SEXUAL INTEREST / AROUSAL DISORDER & STRATEGIES TO OPTIMIZE SEXUAL DESIRE IN WOMEN Dr. Shauna Correia MDCM, FRCPC UBC Sexual Medicine Program SEACRUISES - Sexual Health & Urology - Mediterranean
More informationREVIEW Women s sexual function and dysfunction: current uncertainties, future directions
(2008) 20, 466 478 & 2008 Nature Publishing Group All rights reserved 0955-9930/08 $30.00 www.nature.com/ijir REVIEW : current uncertainties, future directions BC Centre for Sexual Medicine, Vancouver
More informationSexuality, Intimacy and Relationships in Survivorship: A Quality of Life Issue
Sexuality, Intimacy and Relationships in Survivorship: A Quality of Life Issue Sage Bolte, PhD, LCSW, OSW-C Program Coordinator, Oncology Counselor Life with Cancer Inova Cancer Services Fairfax, VA sage.bolte@inova.org
More informationMenopausal Management: What Has Changed?
Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning
More informationLaser CO2: una terapia ambulatoriale innovativa nel trattamento delle disfunzioni sessuali femminili
Obstetrics and Gynaecology Unit Functional Unit of Urogynaecology Vita-Salute San Raffaele University and San Raffaele Hospital Milan Italy Laser CO2: una terapia ambulatoriale innovativa nel trattamento
More informationPhysiology and disturbances of sexual functions Prof. Jolanta Słowikowska-Hilczer, M.D., Ph.D.
Physiology and disturbances of sexual functions Prof. Jolanta Słowikowska-Hilczer, M.D., Ph.D. Department of Andrology and Reproductive Endocrinology Medical University of Łódź, Poland SEXUALITY Sexuality
More informationFEMALE AROUSAL AND ORGASMIC COMPLAINTS IN A DIVERSE CANCER POPULATION TREATED WITH ZESTRA: A TOPICAL APPLIED BLEND OF BOTANICAL OILS
FEMALE AROUSAL AND ORGASMIC COMPLAINTS IN A DIVERSE CANCER POPULATION TREATED WITH ZESTRA: A TOPICAL APPLIED BLEND OF BOTANICAL OILS Michael L Krychman MD Executive Director of the Southern California
More informationSexuality and Bone Marrow Failure Diseases: A Conversation
Sexuality and Bone Marrow Failure Diseases: A Conversation Timothy Pearman, Ph.D. Director, Supportive Oncology Associate Professor Dept. of Medical Social Sciences Dept. of Psychiatry and Behavioral Sciences
More informationEjaculation. Ege Can Serefoglu, MD, FECSM Bagcilar Training & Research Hospital, Istanbul
+ Ejaculation Ege Can Serefoglu, MD, FECSM Bagcilar Training & Research Hospital, Istanbul + Lectures Master lecture 1 - Delayed ejaculation/anorgasmia Emmanuele Jannini (Italy) Taxonomy of ejaculatory
More informationERECTILE DYSFUNCTION PREMATURE EJACULATION. David Goldmeier
ERECTILE DYSFUNCTION PREMATURE EJACULATION David Goldmeier d.goldmeier@nhs.net LEARNING OBJECTIVES Management of erectile dysfunction and premature ejaculation in General Practice Discussion and consideration
More informationCarmita Abdo, MD PhD. Medical School, University of São Paulo Program of Studies in Sexuality (ProSex)
Carmita Abdo, MD PhD Medical School, University of São Paulo Program of Studies in Sexuality (ProSex) Carmita Abdo, MD PhD As per Rule 1595/2000 of the Federal Medical Council and Resolution RDC 102/2000
More informationLow sexual desire: Appropriate use of testosterone in menopausal women
Low sexual desire: Appropriate use of testosterone in menopausal women Low-dose testosterone treatment may be considered for HSDD in carefully selected menopausal women after standard therapies have been
More informationScream Cream. Ingredients: Aminophylline 15-mg, Ergoloid mesylate 0.25-mg, Pentoxifylline 25-mg and L-Arginine 30-mg
At LifeCare Pharmacy we understand that women have different needs at different stages of their lives. Maintaining a healthy and balanced lifestyle can be a difficult struggle. The chronic stress of overly
More informationSexual Side Aspects of Incontinence - Suburethral Sling Surgery - in Women:
Sexual Side Aspects of Incontinence - Suburethral Sling Surgery - in Women: Irwin Goldstein MD Director, Sexual Medicine, Alvarado Hospital, San Diego, California Clinical Professor of Surgery, University
More informationSexual difficulties in the menopause
Sexual difficulties in the menopause Information Sheet Key points Sexual difficulties can be life-long or recently acquired, but they are a common presentation at menopause. Hormones are rarely the only
More informationFemale Sexual Dysfunction: Clinical approach
Female Sexual Dysfunction: Clinical approach - What Nurses want to know - Alessandra Graziottin MD Director, Center of Gynecology and Medical Sexology H.San Raffaele Resnati, Milano, Italy Co-Director,
More informationSexuality and Intimacy. Glynis Cumming MN RN
Sexuality and Intimacy Glynis Cumming MN RN Why is this important? Increasing number of people surviving cancer Increasing awareness of quality of life Cancer and cancer treatments can all impact on sexual
More informationDR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018
DR REBECCA LEVY-GANTT HOT TOPICS IN OBGYN 2018 2018 WHAT S NEW? Contraception: Long Acting reversible contraception Contraception: Birth control pills Vaginal dryness: Treatments Breast density: Diagnosis
More informationI have no disclosures to report. Addressing Female Sexual Needs. Sexual health. Objectives. WHO definition of sexual health:
Addressing Female Sexual Needs I have no disclosures to report Essentials of Women s Health Conference Big Island, Hawaii July 2016 Jennifer Kerns, MD, MS, MPH Assistant Professor, UCSF Department of Obstetrics,
More informationSexuality in Later Life
National Institute on Aging AgePage Sexuality in Later Life Many people want and need to be close to others as they grow older. This includes the desire to continue an active, satisfying sex life. But,
More information